Valuation : Incyte Corporation

Market Cap 2.55TCr 2.2TCr 2.07TCr 1.89TCr 3.53TCr 2,43000Cr 3.54TCr 25TCr 9.48TCr 1,23800Cr 9.59TCr 9.38TCr 3,92300Cr P/E 2026 *
56.2x
P/E 2027 * 17.4x
Enterprise Value 2.13TCr 1.83TCr 1.73TCr 1.57TCr 2.94TCr 2,02800Cr 2.96TCr 20TCr 7.91TCr 1,03300Cr 8TCr 7.83TCr 3,27300Cr EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.12x
Free-Float
98.16%
Yield 2026 *
-
Yield 2027 * -
1 day+1.29%
1 week-2.19%
Current month+2.26%
1 month+4.52%
3 months+22.07%
6 months+29.77%
Current year+27.58%
1 week 122.22
Extreme 122.222
128.08
1 month 117.56
Extreme 117.56
130.8
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
25/08/26 Tax

EVP, Human Resources

-504 0.0002%
19/08/26 Sell

Chairperson

-10,801 0.0053%
12/08/26 Sell

Chairperson

-10,803 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
+1.29%-2.19%+47.21%+96.95% 2.55TCr
-0.33%-5.21%+45.12%-2.77% 8.06TCr
-1.00%-3.42%-19.64%-36.89% 5.91TCr
-3.36%-10.08%+454.19%+25.98% 5.41TCr
+0.83%-3.26%-9.28%+30.44% 5.01TCr
-1.42%-8.61%-3.21%+144.72% 4.53TCr
-0.83%-5.36%+46.75%-18.63% 3.11TCr
-3.92%-8.04%-5.27%+146.34% 2.18TCr
-0.38%-3.74%+64.37%+99.64% 1.61TCr
+1.77%-0.55%+42.21%+167.79% 1.49TCr
Average -0.10%-3.47%+66.24%+65.36% 3.99TCr
Weighted average by Cap. -0.14%-3.73%+76.90%+40.80%

Financials

2026 *2027 *
Net sales 594.19Cr 511.3Cr 481.44Cr 438.67Cr 820.76Cr 57TCr 824.03Cr 5.71TCr 2.21TCr 29TCr 2.23TCr 2.18TCr 91TCr 626.5Cr 539.1Cr 507.62Cr 462.52Cr 865.38Cr 60TCr 868.83Cr 6.02TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 96TCr
Net income 47Cr 40Cr 38Cr 34Cr 64Cr 4.43TCr 65Cr 447.33Cr 172.89Cr 2.26TCr 174.92Cr 171.12Cr 7.15TCr 149.59Cr 128.72Cr 121.2Cr 110.43Cr 206.62Cr 14TCr 207.45Cr 1.44TCr 555.17Cr 7.25TCr 561.69Cr 549.49Cr 23TCr
Net Debt -422.97Cr -363.96Cr -342.71Cr -312.26Cr -584.24Cr -40TCr -586.57Cr -4.06TCr -1.57TCr -21TCr -1.59TCr -1.55TCr -65TCr -599.09Cr -515.52Cr -485.41Cr -442.28Cr -827.52Cr -57TCr -830.82Cr -5.75TCr -2.22TCr -29TCr -2.25TCr -2.2TCr -92TCr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
09/26/09 $126.01 +1.29% 13,01,228
08/26/08 $124.40 -1.85% 12,83,253
04/26/04 $126.75 -0.98% 10,36,073
03/26/03 $128.00 -0.64% 9,10,226
02/26/02 $128.83 +3.06% 23,24,205
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
126.01USD
Average target price
127.74USD
Spread / Average Target
+1.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!